Inventor
BESONG GILBERT EBAI
GB16 patents
⚠️ This page may combine multiple inventors who share the name “BESONG GILBERT EBAI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASTEX THERAPEUTICS LTD
7 patentsUS9303029B2Apr 5, 2016
Substituted quinoxalines as FGFR kinase inhibitors
ASTEX THERAPEUTICS LTD25 citations94
US9464071B2Oct 11, 2016
Pyrazolyl quinoxaline kinase inhibitors
ASTEX THERAPEUTICS LTD24 citations93
US9850228B2Dec 26, 2017
Pyrazolyl quinoxaline kinase inhibitors
ASTEX THERAPEUTICS LTD17 citations91
US10052320B2Aug 21, 2018
Substituted quinoxalines as FGFR kinase inhibitors
ASTEX THERAPEUTICS LTD11 citations84
US10519137B2Dec 31, 2019
Pyrazolyl quinoxaline kinase inhibitors
ASTEX THERAPEUTICS LTD6 citations83
US9856236B2Jan 2, 2018
Substituted quinoxalines as FGFR kinase inhibitors
ASTEX THERAPEUTICS LTD16 citations83
US9145354B2Sep 29, 2015
Pharmaceutical compounds
ASTEX THERAPEUTICS LTD0 citations37
SAXTY GORDON
6 patentsUS9290478B2Mar 22, 2016
Substituted quinoxalines as FGFR kinase inhibitors
SAXTY GORDON25 citations93
US8895601B2Nov 25, 2014
Pyrazolyl quinoxaline kinase inhibitors
SAXTY GORDON25 citations91
US8859582B2Oct 14, 2014
Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
SAXTY GORDON7 citations83
US8076354B2Dec 13, 2011
Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
SAXTY GORDON9 citations83
US8071614B2Dec 6, 2011
Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
SAXTY GORDON16 citations83
US8859583B2Oct 14, 2014
Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
SAXTY GORDON0 citations51